Vancouver, Canada

Paul Goldberg


Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1996-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Paul Goldberg

Introduction

Paul Goldberg is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of genetics and neurobiology, particularly in relation to Huntington's disease. With a total of 2 patents, his work has the potential to influence therapeutic approaches for this challenging condition.

Latest Patents

Goldberg's latest patents focus on apoptosis modulators that interact with the Huntington's disease gene. He identified a family of proteins, including a specific human protein designated as HIP1, which interacts differently with the gene product of a normal and an expanded HD gene. His research indicates that the expression of the HIP1 protein is enriched in the brain and suggests a potential apoptotic function. This understanding of the role of huntingtin and HIP1 in the pathology of Huntington's disease opens up several therapeutic possibilities. For instance, gene therapy could be employed to enhance the expression of normal huntingtin or the HIP-binding region of huntingtin, potentially providing therapeutic benefits.

Another significant patent involves the process for isolating genes and identifying the gene causative of Huntington's disease. The underlying genetic defect has been mapped to chromosomal band 4p16.3, with refined localization identifying two distinct candidate regions. His work has led to the mapping of several clones within the minimal region containing the HD gene, which are particularly useful in detecting changes in this portion of the gene in HD patients.

Career Highlights

Throughout his career, Paul Goldberg has worked with esteemed institutions such as the University of British Columbia and HSC Research and Development Limited. His research has contributed to a deeper understanding of genetic factors in neurodegenerative diseases.

Collaborations

Goldberg has collaborated with notable colleagues, including Michael R. Hayden and Michael Kalchman, further enhancing the impact of his research in the scientific community.

Conclusion

Paul Goldberg's innovative work in the field of genetics, particularly concerning Huntington's disease, showcases his dedication to advancing medical science. His patents and research have the potential to pave the way for new therapeutic strategies, ultimately benefiting those affected by this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…